Emisphere Technologies, Inc. (OTC BB:EMIS) announced that interim data from an ongoing study demonstrated its high-dose oral Eligen® B12 (1000mcg) performed as well as or better than B12 injections in individuals with Vitamin B12 deficiency. more
Madeleine Moon MP writes for ePolitix.com about tonight's adjournment debate on pernicious anaemia. more
Want your website to be on this Glue Page? Sign up now.
Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy
| Terms of Service
| Copyright/IP Policy
| Report Abuse
| Directory
| Help